Despite meeting the primary endpoints in a Phase 3 trial, shares of Zealand Pharma dropped in premarket trading Thursday as ...
Novocure (Nasdaq: NVCR) announced today that Japan’s Ministry of Health, Labour and Welfare (MHLW) approved Optune Pax ® for ...
Note: Statistically significant differences are in bold. Source: Spring 2026 Global Attitudes Survey and survey of U.S. adults conducted Jan. 30-June 18, 2026. Fresh data delivered Saturday mornings ...
Note: Only the U.S. and countries with statistically significant changes are shown. Highlighted countries include places where roughly eight-in-ten now say “more divided”. Over time, we have changed ...
Boehringer Ingelheim’s survodutide achieves up to 13.1% weight loss in new Phase III trial, alongside significant improvements in glycemic control in people with obesity and type 2 diabetes ...
Quality of vision and subjective experience in children wearing SightGlass Vision Diffusion Optics Technology were similar to single vision spectacle lens wear, according to two studies presented at ...
The Day Numbers Become a Weapon in the Field of Social WelfareWhen I entered the master's program for social welfare, to be ...
The bullish thesis for uniQure’s gene therapy for Huntington's disease is still intact, as evident in consistent and positive ...
Louisiana’s adult obesity rate dropped significantly last year, making it one of just two states in the country to see a ...
Systemwide air conditioning could cost approximately $1.5 billion, making the mandate one of the largest institutional HVAC ...
North-eastern KwaZulu-Natal remains a hot spot of adult illiteracy, while Gauteng’s and Western Cape’s strong cold spots ...
Giredestrant plus everolimus doubled median progression-free survival in advanced ER-positive breast cancer with ESR1 mutations. The study involved patients whose disease had progressed on CDK4/6 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results